FRG2LP

Across TCGA pan-cancer cohorts, FRG2LP RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated FRG2LP data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher FRG2LP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FRG2LP expression acts as an unfavorable survival marker, although some lineages such as ESCA and TGCT show a favorable association.

UCS, LUSC, and READ are the cancer types where FRG2LP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.102	0.688	<.001	108	view →
LUSC	DFS	Tertile	All	0.473	0.764	<.001	87	view →
READ	DFS	Tertile	All	0.027	0.845	<.001	72	view →
OV	OS	Tertile	IV	0.272	0.765	.005	36	view →
LUAD	DFS	Tertile	II,III,IV	0.226	0.526	.026	27	view →
SKCM	OS	Tertile	III,IV	0.446	0.814	.002	18	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.367	.021	18	view →
TGCT	DFS	Tertile	All	1.000	0.627	.022	18	view →
UCEC	DFS	Tertile	All	0.788	0.904	.011	12	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →
THCA	OS	Tertile	All	0.620	0.930	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

FRG2LP–UCS (OS)

Open the UCS breakdown →